Snowball logo
logo
CTY

City Therapeutics, Inc. Common Stock

CTY β€’ NASDAQ
$21.49+$0.70Β  (3.37%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20152016201720182019TTM
Revenue
Total revenue
8,9648,9108,5508,4938,1576,493
COGS
2,8722,9342,8812,7672,4382,206
Gross Profit
6,0925,9765,6695,7265,7194,287
Operating Expenses & Income
Operating Income
2,2602,3222,3132,6602,8842,832
Total Operating Expenses
6,7046,5886,2375,833659(1,655)
R&D Expenses
------
Selling General & Admin Expenses
1,0151,022925799659627
Earnings from Continuing Operations
Interest Expense
(473)(478)(465)(448)-(381)
Interest Income
------
Income Tax Expense
659678134494641633
Net Income
Net Income
1,0741,0851,6571,6651,8271,796
Supplemental
EBIT
2,2062,2412,2562,6072,4682,238
EBITDA
4,0453,9203,8374,0443,8323,584
In millions of USD, except % and values per 1 share